Gastroenterology
Conference Coverage
Debulking called reasonable for unresectable liver cancer
When advanced neuroendocrine liver cancer is unresectable, is debulking an appropriate option?
Conference Coverage
Preparing for pancreatic cancer ‘tsunami’ ahead
Overall cancer death rates are dropping dramatically, but pancreatic cancer mortality remains high.
Conference Coverage
Transanal TME comparable to open, lap approaches to rectal cancer
Transanal total mesorectal excision can consistently achieve good pathological results for obtaining specimens in rectal cancer, a study has found...
Conference Coverage
Neoadjuvant chemoradiation may give transplant the edge over resection in biliary cancer
MIAMI BEACH - The optimal surgical treatment of hilar cholangiocarcinoma is still controversial.
Conference Coverage
BRCA2 mutations linked to greater risk for pancreatic cancer
MIAMI BEACH – A higher incidence of pancreatic abnormalities on imaging among BRCA2 mutation carriers may provide a potential screening target.
Conference Coverage
Dual targeting effective in HER2+ metastatic colorectal cancer
A combination of two drugs resulted in a 30% objective response rate in heavily pretreated patients with HER2-positive metastatic colorectal...
From the Journals
VIDEO: Occult cancers contribute to GI bleeding in anticoagulated patients
Significant morbidity, long hospital stays, and required transfusions result from treatment-related GI bleeding events.
From the Journals
Aggressive HCC in males traced to higher serotonin
Serotonin was shown to be crucial for activating hepatic stellate cells during HCC carcinogenesis.
Conference Coverage
Disease site determines QOL, pain in recurrent rectal cancer
SEATTLE – Posterior recurrence was associated with the worst quality of life and most severe pain.
From the Journals
Antiviral medication successful for treating HCV in hepatocellular carcinoma
DAAs can successfully treat even patients who have received liver transplants.
From the Journals
Colorectal tumors: ESD passes long-term test
In superficial colorectal tumors, over a minimum of 5 years of follow-up, endoscopic submucosal dissection was effective and generally safe.